The Bioactive Team
Rick is the Founder and Managing Director of Bioactive Laboratories. He has a commerce technology degree from Curtin University in Perth, Western Australia.
Early in his career, Rick worked in ‘Translational Medicine’ as a software engineer for the Wellcome Foundation medical research facility in London, UK. He developed a bespoke clinical trials system for one of the world’s first anti-viral drugs, AZT. From there, Wellcome Pharmaceuticals production facility seconded Rick to redevelop several production and commercial systems.
Since then he has been involved in many industries that range from, taxation and telecommunications, contrasted with agro-forestry & livestock, now in biotech combining pharmaceutical drug discovery with natural medicines development, always specialising in innovative projects.
Rick’s first start-up was in telecommunications winning the accolade of Best Small Business Communications Solution in Australia for a speech recognition integrated telephone messaging service. A serial entrepreneur, Rick has been commercialising technology R&D outcomes for over 20 years.
Immediately prior to Bioactive, he managed an R&D program where plant genetic selection led to an improved outcome, specifically with one of the key Bioactive plant species.
As the Bioactive founder, Rick developed the unique Business Model incorporating drug discovery with TGA approved natural health discoveries. He continues to manage the early stage R&D program, the product pipeline, production and commercialisation, taking advice from senior industry figures as mentors.
Rick has been successful in raising private funds and has received government grants for Bioactive. In prior businesses, Rick has raised over $5M from venture capital, grants and sophisticated investors.
One notable humanitarian project is where he successfully achieved a multi-million-dollar AusAid grant, negotiated as a JV with the European Investment Bank for a project in the Pacific Islands.
Rick was born in Perth, Western Australia from immigrant parents who arrived with a forward looking attitude and a strong work ethic. Time devoted to a task (this includes children) together with education were his family’s major drivers, influenced via his parents and five older siblings.
He is married with two adult daughters. The family loves sharing time together diving and snorkling around the pristine coral archipelagos that surround Australia. Their rural exposure is a constant source of inspiration and life balance with medicinal tree species and livestock providing the foundation for human and veterinary medicine discoveries.
Rick is the Chairman of an overseas charity that he co-founded with a school friend in 2005. It is primarily devoted to the education, health and welfare needs of under privileged women and children.
 Wellcome Pharmaceuticals merged into GSK-GlaxoSmithKline
Prof Anthony Carroll – Head Research Consultant & Advisory
Tony is currently Professor at the Griffith Institute for Drug Discovery. He specialises in Biodiscovery involving screening against molecular targets, isolation and structure elucidation of bioactive natural substances.
He has a keen interest in the fields of anti-microbial and neurodegenerative diseases.
His network of affiliate researchers and research institutions spans across the globe as does his reputation within the field of new compound discoveries.
Clare is a co-founder and senior executive.
She has over 30 years experience in business management, specifically in technology project management and business education.
Highly regarded, Clare has a diverse set of industry experiences from her government work, taking on senior management roles at the Australian Taxation Office, Attorney Generals Dept and the Dept of Defence in Canberra, to her extensive experience in the private sector, most notably her position as the senior technology consultant to the trading room floor at a large Merchant Bank in London, to most recently in the Oil and Gas industry as a senior technical consultant at Chevron in Perth.
Clare has been instrumental in managing all aspects of the Khapregesic® on-line business from social media, monitoring analytics to educating practitioners and customer service.
Caroline Robertson – Senior Clinical Consultant and Advisory.
Caroline is a Clinical Naturopath and Ayurveda Practitioner with over 30 years’ experience. With a keen focus on Women’s Health, Caroline is a natural therapies author, clinical case study supervisor, and practices on-line & clinic-based consultations in the Northern Beaches suburb of Mona Vale in Sydney, Australia.
In addition to Caroline’s Naturopathic Practice, she has extensive community retail experience dispensing natural listed medicines and supplements, giving compassionate health advice to a wide variety people in the Australian community.
Sarah Rendell – Senior Marketing Consultant & Advisory
Sarah is the Marketing Manager for Pharmacy Specialist Firm, Peak Strategies. Working with healthcare clientele Sarah builds a strong digital presence for her clients, specialising in community pharmacy.
She has a wealth of experience in both B2C and B2B marketing with a keen interest in social media. Some of her work has been featured on the Australian Journal of Pharmacy. Sarah is on the prestigious advisory board for Pharmacy Guild of Australia’s Future Pharmacy Program.
Dr Sandy Chien – Senior Consultant & Advisory, US Market & FDA Regulatory
Sandy is based in the USA, she has a broad background in IP, regulatory and new product development in the US Listed Medicines industry.
Sandy was the principal inventor of a series of new chromium molecules that are being patented and commercialized as supplements for insulin management.
Dr. Xiaoming “Sandy” Chien received her Ph.D degree from the University of California, in Materials. Her main research was in multistep organic synthesis of conducting polymers. She collaborated with Alan Heegar who received the Nobel Prize for Chemistry in 2000 & published papers in many peer-reviewed journals.
Sandy has completed a US market report for Khapregesic® and when the time comes will guide the company through its export options and facilitate the FDA regulatory requirements for Khapregesic®.
Paul has facilitated commercial deals in areas such as novel therapeutics, biomarkers, medical devices and other technologies developed by Australian breitling replica watches biotech companies and research institutions.
He has held senior management positions at Austrade, Bio-Link, ATP Innovations, Cellabs and the University of Technology, Sydney (UTS) and currently serves on the Boards of the Victoria Cancer Biobank and the Global Health Alliance Melbourne.
As a private company in the early stages of commercialisation, the wider Bioactive Team is made up of consultants and contract organisations. Bioactive adopts a lean approach to investor funds by not appointing permanent paid board members. Bioactive has an array of mentor and advisory who span several disciplines.
Potential investors can find out more by contacting Rick Ferdinands through the Contact Us link.